Company Overview and News
The broader indices are trading on a negative note this Monday afternoon with the Nifty down 9 points at 10,808 and the Sensex is trading lower by 32 points at 35,589.
IOC PAGEIND 534816 BJJQY PGDQY AXB TATAPOWER 532827 530965 JSWSTEEL AXBA BAJFINANCE BATAINDIA TATASTEEL TATLY KOTAKBANK TCS 500188 HINDZINC BHRYY 500228 HNDZY 533155 TTNQY JUBLFOOD 532215 532654 500470 532540 AXISBANK ENGINERSIN JBLWY INFRATEL 500034 MCLEODRUSS HINDALCO KMBKY IBN 539207 AXBKY HNDNF 532178 ICICIBANK TTST 532174 TPCL 500400 500247 500043 MANPASAND 500440
The broader indices are trading on a negative note this Monday morning with the Nifty down 22 points at 10,795 and the Sensex is trading lower by 65 points at 35,557.
IOC PAGEIND ICLQY 532832 534816 BJJQY PGDQY AXB TATAPOWER 532827 YYBKY 530965 532822 JSWSTEEL AXBA BAJFINANCE BATAINDIA TATASTEEL TATLY TCS IBREALEST 500188 HINDZINC BHRYY 500228 HNDZY 533155 TTNQY JUBLFOOD 532215 532654 500470 532540 AXISBANK JBLWY INFRATEL 503100 500034 YESBANK MCLEODRUSS HINDALCO PHOENIXLTD IBN 532648 539207 AXBKY HNDNF ICICIBANK TTST 532174 IDEA TPCL 500400 500043 MANPASAND 500440
The broader indices are trading weak this Wednesday afternoon, with the Nifty down 46 points at 10,587 and the Sensex shedding 131 points at 34,818.
GRASIM BHUSANSTL DABUR TCHQY ICLQY MARKSANS 532712 532755 DBRQY 532960 JUSTDIAL 500096 PIDILITIND RCOM 534816 PDLTY 500179 BJJQY BEL CLNDY 500055 500331 BHQRY 524404 GRSJY CLGQY 532822 TECHM 500380 BAJFINANCE TATASTEEL TATLY 500300 HINDPETRO JKLAKSHMI 500104 COALINDIA 500188 HINDZINC BHRYY GODREJIND HNDZY 533155 BHRQY JUBLFOOD 533278 IDBLZ HCL-INSYS 500470 535648 CL JBLWY RADICO INFRATEL BHARTIARTL TWL 500034 HINDALCO IBVENTURES IBN 532966 532454 HNDNF GRSXY 532497 ICICIBANK TTST 532174 IDEA 500049 500164 JSTQY 500440
“Four hundred beds (worth Rs50 lakh) in this hospital were sponsored by Sterlite Industries,” reads a plaque, written in Tamil, on the wall facing the entrance to the fifth floor of the Government Medical College and Hospital in Thoothukudi.
HNDZY MRZUY VEDL 532500 VED MARUTI LNSTY 500570 TATAMOTORS 500188 HINDZINC SBAZ TTM
London: Billionaire industrialist Anil Agarwal plans to leave behind a legacy: an Indian resources group to rival the world’s biggest.
AULGF VED AAUKF AU HNDZY AAL AGG NGLOY VEDL 500188 HINDZINC
The market is trading on a negative note on Wednesday morning, with the Nifty down 37 points at 10,499 and the Sensex down 100 points at 34,550.
IOC 500325 BHUSANSTL PIDILITIND 532483 PDLTY UCLQY 500570 500055 RLNIY 500331 SBAZ 530965 ULTRACEMCO CNRYY TATASTEEL TATLY 534809 PCJEWELLER CANBK 500188 HINDZINC ANDHRABANK 524715 HINDCOPPER RELIANCE 532418 532538 HNDZY 500470 532461 ENGINERSIN RIGD 500031 TATAMOTORS TWL UBNC HINDALCO 513599 UCLQF 532966 HNDNF 532178 TTST PNJZY SUNPHARMA PNB BAJAJELEC 500440 TTM
The stock of Hindustan Zinc fell by 5.8 per cent on Wednesday, owing to a drop in the March quarter net profit by 18 per cent y-o-y. The weak production guidance given by the company for fiscal 2018-19 has further dampened sentiments. However, a ramp-up in production in the company’s underground mines, higher consistency in grade levels and expected lower cost of production over the next two to three years, remain positives for the stock.
HNDZY 500188 HINDZINC
Benchmark indices ended rangebound session on a flat note Wednesday but the broader markets underperformed, with the Nifty Midcap index falling 1.5 percent and BSE Smallcap declining over a percent amid earnings.
INDIANB 500325 HCTHY JUSTDIAL 532483 532281 EICHERMOT RLNIY AXB JETAIRWAYS YYBKY CNRYY 500182 AXBA TATASTEEL FORTIS TATLY HCLTECH 500180 KOTAKBANK 534809 PCJEWELLER CANBK 500188 HINDZINC GODREJIND RELIANCE 532617 532814 HNDZY 532215 505200 532541 500470 535648 AXISBANK RIGD HDFCBANK HEROMOTOCO YESBANK NIITTECH INDIGO ECQRY KMBKY IBN 532648 532843 539448 AXBKY ICICIBANK TTST HDB 532174 HRTQY 500247 500164 JSTQY
3:30 pm Market Closing: The market closed flat after rangebound session, as investors await Federal Reserve meeting outcome due tonight.
BAJAJ-AUTO INDIANB 500325 MUNJALSHOW DABUR HCTHY DBRQY JUSTDIAL 5225 500096 523371 532483 500696 532281 AJANTPHARM 500570 EICHERMOT CLNDY RLNIY ASHOKLEY AXB TATAPOWER 532947 532749 507490 JETAIRWAYS IRB AKLD CNRYY 500182 AXBA FORTIS HCLTECH 500180 KOTAKBANK 534809 PCJEWELLER LITL CANBK Q0F COALINDIA AKLS SSWL 500188 HINDZINC 513262 GODREJIND RELIANCE 532617 532814 HINDUNILVR HNDZY 532977 532778 533278 532215 505200 IBRQY 532541 535648 AXISBANK ALLCARGO RIGD HDFCBANK HEROMOTOCO 500477 520043 RANASUG IHHHF TATAMOTORS NIITTECH INDIGO ECQRY 500710 KMBKY IBN 532843 539448 AXBKY MAWANASUG ICICIBANK 532331 RAMCOSYS HDB 532174 AKZOINDIA 532370 TPCL 500400 HRTQY 500247 500164 JSTQY TTM
The Indian equity market was trading on a flat to positive note on Wednesday afternoon with the Nifty shedding 6 points was trading at 10,732 while the Sensex was up 42 points or 0.12 percent.
GRASIM PWQFY DABUR HCTHY TCHQY FEDA TTQQY 532712 532514 511389 ASIANPAINT 532755 DBRQY TATACHEM 532960 IGL JUSTDIAL 500096 RCOM FEDS 500696 532281 FEDERALBNK 500770 GRSJY TVSMOTOR FDBAY JSWSTEEL TECHM TATASTEEL TATLY HCLTECH 500180 KOTAKBANK 500300 534809 PCJEWELLER 500188 HINDZINC 524715 HINDCOPPER 500820 500469 500228 HINDUNILVR HNDZY 533155 VIDEOIND 532810 JUBLFOOD IDBLZ 532343 500470 535648 JBLWY HDFCBANK ZEEL HINDALCO KMBKY IBVENTURES IBN 513599 PFC HNDNF GRSXY ICICIBANK TTST ZEEEY HDB 532174 505537 SUNPHARMA 500247 JSTQY 500440
The Indian equity market was trading on a flat to positive note on Wednesday afternoon with the Nifty adding 9 points was trading at 10,749 while the Sensex was up 83 points or 0.24 percent.
BAJAJ-AUTO 500325 DABUR HCTHY TCHQY FEDA 532712 511389 ASIANPAINT 532755 DBRQY 532960 500096 RCOM FEDS 500696 532281 GAILF FEDERALBNK RLNIY AXB FDBAY TECHM AXBA TATASTEEL TATLY HCLTECH GAILY KOTAKBANK 534809 PCJEWELLER 500188 HINDZINC 500820 500469 RELIANCE HINDUNILVR HNDZY 532977 533155 VIDEOIND JUBLFOOD IDBLZ 532215 500470 AXISBANK RIGD JBLWY ZEEL HINDALCO KMBKY IBVENTURES IBN AXBKY HNDNF ICICIBANK TTST ZEEEY 532174 505537 500247 500440
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
HNDZY 500188 HINDZINC
The Indian equity market was trading on a flat to negative note on Wednesday morning with the Nifty shedding 9 points was trading at 10,729 while the Sensex was down 11 points.
BAJAJ-AUTO 500325 DABUR HCTHY TCHQY 532712 511389 532755 DBRQY 532400 KPIT 532960 500096 RCOM 500696 532281 GAILF 500570 CLNDY RLNIY TECHM HCLTECH GAILY KOTAKBANK 534809 HINDPETRO PCJEWELLER 500104 COALINDIA 500188 HINDZINC 532939 RELIANCE HINDUNILVR HNDZY 532977 533155 VIDEOIND JUBLFOOD 533278 IDBLZ RIGD JBLWY ZEEL TATAMOTORS RPOWER KMBKY IBVENTURES ZEEEY 505537 500247 TTM
TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- Potash Ridge Corporation (the “Company”) (TSX:PRK) is pleased to announce the addition of E. Richard Klue, B.Com, NHD Ext.Met. to the Board of Directors of Potash Ridge Corporation.
PRK POTRF AAUKF CCK HNDZY AAL CCB BRUZF NGLOY CDCLD 500188 HINDZINC
2018-06-18 - Asif
Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...
2018-06-11 - Asif
Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...
2018-06-11 - Asif
Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...